LON/0R0O (LON/0R0O)

London Stock Exchange: LON/0R0O · USD

$413

+1.68 (+0.4%)· Recorded snapshot

Market cap	278.4B
Revenue (ttm)	339B
Net income (ttm)	12B
EPS (ttm)	$13.2
P/E (trailing)	23.6x
P/E (forward)	18.3x
Dividend	$6.98 (2.25%)
Volume	4,348
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 339B
Net income (ttm): 12B
EPS (ttm): $13.2
P/E (trailing): 23.6x
P/E (forward): 18.3x
Market cap: 278.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.3

P25 n/aP50 n/aP75 n/a

Trailing P/E23.6

P25 n/aP50 n/aP75 n/a

ROE15.8

P25 n/aP50 n/aP75 n/a

ROIC12.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0R0O indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-13
Employees	390,000
Employees change	-40,000
Employees growth	-9.09%
Enterprise value	$315.9B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1974
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US91324P1021
Last earnings date	2026-10-13
Last refreshed	2026-10-28
Market cap	$278.4B
Next earnings date	2027-01-12
Price	$412.67
Price currency	USD
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	lon/0R0O
Website	https://www.unitedhealthgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.39x
Average P/E ratio (3Y)	25.01x
Average P/E ratio (5Y)	24.72x
Earnings yield	4.24%
EV/Earnings	26.27x
EV/EBIT	15.88x
EV/EBITDA	13.71x
EV/FCF	18.28x
EV/Sales	0.93x
FCF / EV yield	5.47%
FCF yield	6.21%
Forward P/E	18.28x
Graham number	217.19437
Graham upside	-47.15%
Lynch fair value	$88.82
Lynch upside	-78.39%
P/(FCF - SBC) ratio	16.85x
P/(OCF - SBC) ratio	14.6x
P/B ratio	3.48x
P/E ratio	23.59x
P/FCF ratio	16.1x
P/OCF ratio	14.03x
P/S ratio	0.82x
Price / tangible book value	3.53x
Price/EBITDA ratio	12.72x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.85%
EBITDA margin	6.42%
Effective tax rate	15.54%
FCF margin	5.08%
Gross margin	20.05%
Operating margin	5.85%
Pretax margin	4.38%
Profit margin	3.53%
Profit per employee	$30,678
Profitable quarters	9
Profitable years	27
Revenue per employee	$869,225
ROA	5.24%
ROA (5Y)	6.86%
ROCE	13.38%
ROE	15.77%
ROE (5Y)	20.42%
ROIC	12.39%
ROIC (5Y)	14.86%
SBC / revenue	0.23%
Tax / revenue	0.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-8.96%
EPS growth (Q)	75.93%
EPS growth (QoQ)	-24.56%
EPS growth 10Y	9.96%
EPS growth 3Y	-8.76%
EPS growth 5Y	1.66%
EPS growth quarters	2
EPS growth years	0
FCF growth	31.4%
FCF growth (Q)	-15.65%
FCF growth (QoQ)	-58.41%
FCF growth 3Y	-4.78%
FCF growth 5Y	-0.06%
Net income growth	-9.69%
Net income growth (Q)	75.04%
Net income growth (QoQ)	-25.05%
Net income growth 3Y	-9.86%
Net income growth 5Y	0.59%
Net income growth quarters	1
Net income growth years	0
OCF growth	24.99%
OCF growth (Q)	-13.83%
OCF growth (QoQ)	-53.65%
OCF growth 10Y	5.94%
OCF growth 3Y	-4.13%
OCF growth 5Y	0.76%
Revenue growth	3.42%
Revenue growth (Q)	-0.41%
Revenue growth (QoQ)	0.59%
Revenue growth 10Y	9.54%
Revenue growth 3Y	7.73%
Revenue growth 5Y	10.01%
Revenue growth quarters	126
Revenue growth years	33

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.5B
EBIT	$19.8B
EBITDA	$21.8B
EPS	$13.17
Financing cash flow	$-12.1B
Free cash flow	$17.2B
Free cash flow minus SBC	$16.4B
Gross profit	$68B
Income taxes	$2.3B
Investing cash flow	$-8.6B
Net borrowing	$-3.6B
Net cash flow	$-1B
Net income	$12B
Operating cash flow minus SBC	$19B
Operating income	$19.8B
Revenue	$339B
Stock-based compensation	$767.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$86.95
Debt / EBITDA	2.44
Debt / equity	0.7
Debt / FCF	3.26
Interest coverage	6.84
Net cash (debt)	$-36.5B
Net cash / market cap	-13.19%
Net debt / EBITDA	1.68
Net debt / equity	0.46
Net debt / FCF	2.12
Piotroski F-Score	6
Shareholders' equity	$79.5B
Tangible book value	$78.4B
Tangible book value per share	$86.95
Total assets	$235.6B
Total cash	$21.5B
Total debt	$56B
Total liabilities	$156.1B
WACC	7.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.43
Current ratio	0.74
Net working capital	$-38B
Quick ratio	0.42
Working capital	$-22.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.98%
Dividend growth	5.1%
Dividend growth (10Y)	28.29%
Dividend growth (3Y)	8.67%
Dividend growth (5Y)	10.9%
Dividend growth years	8
Dividend payment date	2026-09-22
Dividend payment years	9
Dividend payout frequency	Quarterly
Dividend per share	$6.98
Dividend yield	2.25%
Ex-dividend date	2026-09-14
Last dividend	$2.32
Payout ratio	51.45%
Shareholder yield	3.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$385.69
1D price change	0.41%
1M price change	9.23%
1M total return	9.23%
1W price change	-2.24%
1W total return	-2.24%
1Y price change	12.33%
1Y return CAGR	15.33%
1Y total return	15.32%
20-day SMA	$394.61
200-day SMA	$362.80
3M price change	-1.74%
3M total return	-1.13%
3Y price change	-21.64%
3Y return CAGR	-5.87%
3Y total return	-16.6%
50-day SMA	$389.73
50-day SMA vs 200-day SMA	50over200
52-week high	$461.00
52-week high date	2026-07-16
52-week low	$254.75
52-week low date	2026-03-30
5Y price change	-9.49%
5Y return CAGR	-0.2%
5Y total return	-0.98%
6M price change	16.75%
6M total return	18.14%
All-time high	$630.07
All-time high date	2024-11-11
All-time low	$193.80
All-time low date	2020-03-23
Average true range (ATR)	$13.04
Average volume	7.3K
Beta (5Y)	0.62
Change from 52-week high	-10.48%
Change from 52-week low	61.99%
Change from all-time high	-34.77%
Change from all-time low	112.07%
Change from open	1.05%
Day's gap	-0.64%
Dollar volume	$1.8M
High price	$416.27
Low price	$404.92
Monthly RSI	51.55
Open price	$408.38
Position in 52-week range	68.28%
Previous close	$410.99
Price vs 150-day SMA	6.56%
Price vs 20-day SMA	4.15%
Price vs 200-day SMA	13.28%
Price vs 50-day SMA	5.46%
Relative volume	0.61
RSI	59.66
Sharpe ratio	0.49
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	0.15
Sortino ratio	0.84
Sortino ratio (3Y)	0.2
Sortino ratio (5Y)	0.33
Volume	4.3K
Weekly RSI	60.04
YTD price change	24%
YTD total return	26.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	895M
Shares change (QoQ)	-0.44%
Shares change (YoY)	-0.98%
Shares held by insiders	0.17%
Shares held by institutions	88.98%
Short ratio	2.8 days

Deeper analysis on LON/0R0O

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0R0O report

Is a complete LON/0R0O research report available?

No complete published report is available for lon/0R0O (LON/0R0O) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0R0O (LON/0R0O)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R0O

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R0O indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R0O

Frequently asked questions